{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:52:29Z","timestamp":1775339549488,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03663-w","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T07:01:49Z","timestamp":1742626909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Construction and validation of a novel nomogram for prediction of lymph node metastasis in HER2-positive breast cancer: based on the optimal number of examined lymph nodes for accurate nodal staging"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhen-Dong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Qin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Dong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Han","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"1","key":"3663_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3663_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjsurg.2022.12.009","volume":"225","author":"A Esposito","year":"2023","unstructured":"Esposito A, et al. Characteristics, treatment and outcomes of HER2 positive male breast cancer. Am J Surg. 2023;225(3):489\u201393. https:\/\/doi.org\/10.1016\/j.amjsurg.2022.12.009.","journal-title":"Am J Surg"},{"issue":"2","key":"3663_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain SM, Shastry M, Hamilton E. Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug Discov. 2023;22(2):101\u201326. https:\/\/doi.org\/10.1038\/s41573-022-00579-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3663_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-022-06686-1","volume":"195","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study. Breast Cancer Res Treat. 2022;195(3):301\u201310. https:\/\/doi.org\/10.1007\/s10549-022-06686-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3663_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.6004\/jnccn.2022.7016","volume":"20","author":"LM Spring","year":"2022","unstructured":"Spring LM, Bar Y, Isakoff SJ. The evolving role of neoadjuvant therapy for operable breast cancer. J Natl Compr Canc Netw. 2022;20(6):723\u201334. https:\/\/doi.org\/10.6004\/jnccn.2022.7016.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"3663_CR6","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1245\/s10434-020-09244-5","volume":"28","author":"K Stahl","year":"2021","unstructured":"Stahl K, et al. Benefits of surgical treatment of stage IV breast cancer for patients with known hormone receptor and HER2 status. Ann Surg Oncol. 2021;28(5):2646\u201358. https:\/\/doi.org\/10.1245\/s10434-020-09244-5.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3663_CR7","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1245\/s10434-020-08310-2","volume":"27","author":"R Mudgway","year":"2020","unstructured":"Mudgway R, et al. The impact of primary tumor surgery on survival in HER2 positive stage IV breast cancer patients in the current era of targeted therapy. Ann Surg Oncol. 2020;27(8):2711\u201320. https:\/\/doi.org\/10.1245\/s10434-020-08310-2.","journal-title":"Ann Surg Oncol"},{"key":"3663_CR8","doi-asserted-by":"publisher","unstructured":"Giaquinto AN et al. Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 2022; 72(6): pp. 524\u2013541.https:\/\/doi.org\/10.3322\/caac.21754","DOI":"10.3322\/caac.21754"},{"issue":"4","key":"3663_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ijrobp.2010.03.038","volume":"80","author":"SL Wang","year":"2011","unstructured":"Wang SL, et al. Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy. Int J Radiat Oncol Biol Phys. 2011;80(4):1095\u2013101. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3663_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12936-020-03489-x","volume":"19","author":"J Abeles","year":"2020","unstructured":"Abeles J, Conway DJ. The Gini coefficient as a useful measure of malaria inequality among populations. Malar J. 2020;19(1):444. https:\/\/doi.org\/10.1186\/s12936-020-03489-x.","journal-title":"Malar J"},{"issue":"1","key":"3663_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12955-020-01356-6","volume":"18","author":"HY Wang","year":"2020","unstructured":"Wang HY, et al. Comparison of Ferguson\u2019s \u0394 and the Gini coefficient used for measuring the inequality of data related to health quality of life outcomes. Health Qual Life Outcomes. 2020;18(1):111. https:\/\/doi.org\/10.1186\/s12955-020-01356-6.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3663_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12939-022-01749-7","volume":"21","author":"G Dai","year":"2022","unstructured":"Dai G, Li R, Ma S. Research on the equity of health resource allocation in TCM hospitals in China based on the Gini coefficient and agglomeration degree: 2009\u20132018. Int J Equity Health. 2022;21(1):145. https:\/\/doi.org\/10.1186\/s12939-022-01749-7.","journal-title":"Int J Equity Health"},{"issue":"181","key":"3663_CR13","doi-asserted-by":"publisher","first-page":"20210223","DOI":"10.1098\/rsif.2021.0223","volume":"18","author":"E Heinrich Mora","year":"2021","unstructured":"Heinrich Mora E, et al. Scaling of urban income inequality in the USA. J R Soc Interface. 2021;18(181):20210223. https:\/\/doi.org\/10.1098\/rsif.2021.0223.","journal-title":"J R Soc Interface"},{"issue":"1","key":"3663_CR14","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1038\/s41598-023-40992-y","volume":"13","author":"H Le","year":"2023","unstructured":"Le H, et al. The fuzzy Kullback-Leibler divergence for estimating parameters of the probability distribution in fuzzy data: an application to classifying Vietnamese herb leaves. Sci Rep. 2023;13(1):14537. https:\/\/doi.org\/10.1038\/s41598-023-40992-y.","journal-title":"Sci Rep"},{"key":"3663_CR15","doi-asserted-by":"publisher","unstructured":"Boughey JC, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","DOI":"10.1001\/jama.2013.278932"},{"key":"3663_CR16","doi-asserted-by":"publisher","unstructured":"Takahashi M, et al. Correlation between clinical nodal status and Sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy. World J Surg. 2012;36(12):2847\u201352. https:\/\/doi.org\/10.1007\/s00268-012-1704-z.","DOI":"10.1007\/s00268-012-1704-z"},{"key":"3663_CR17","doi-asserted-by":"publisher","unstructured":"Alvarado R, et al. The role for Sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol. 2012;19(10):3177\u201384. https:\/\/doi.org\/10.1245\/s10434-012-2484-2.","DOI":"10.1245\/s10434-012-2484-2"},{"issue":"12","key":"3663_CR18","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1245\/s10434-022-12064-4","volume":"29","author":"SB Sanders","year":"2022","unstructured":"Sanders SB, et al. Factors influencing Non-sentinel lymph node involvement in patients with positive Sentinel lymph node(s) after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2022;29(12):7769\u201378. https:\/\/doi.org\/10.1245\/s10434-022-12064-4.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3663_CR19","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1245\/s10434-018-6578-3","volume":"25","author":"AU Barron","year":"2018","unstructured":"Barron AU, Hoskin TL, Boughey JC. Predicting Non-sentinel lymph node metastases in patients with a positive Sentinel lymph node after neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25(10):2867\u201374. https:\/\/doi.org\/10.1245\/s10434-018-6578-3.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3663_CR20","first-page":"997","volume":"28","author":"E Zack","year":"2001","unstructured":"Zack E. Sentinel lymph node biopsy in breast cancer: scientific rationale and patient care. Oncol Nurs Forum. 2001;28(6):997\u20131005. quiz 1006-7.","journal-title":"Oncol Nurs Forum"},{"key":"3663_CR21","doi-asserted-by":"publisher","unstructured":"Belmonte R, et al. Long thoracic nerve injury in breast cancer patients treated with axillary lymph node dissection. Support Care Cancer. 2015;23(1):169\u201375. https:\/\/doi.org\/10.1007\/s00520-014-2338-5.","DOI":"10.1007\/s00520-014-2338-5"},{"key":"3663_CR22","doi-asserted-by":"publisher","unstructured":"Rizzi SK, et al. Winged scapula incidence and upper limb morbidity after surgery for breast cancer with axillary dissection. Support Care Cancer. 2016;24(6):2707\u201315. https:\/\/doi.org\/10.1007\/s00520-016-3086-5.","DOI":"10.1007\/s00520-016-3086-5"},{"key":"3663_CR23","doi-asserted-by":"publisher","unstructured":"Zhuge L, et al. The minimal number of examined lymph nodes for accurate nodal staging and favorable prognosis in T1-2 supraglottic laryngeal squamous cell carcinoma. Eur J Surg Oncol. 2023;49(10):107041. https:\/\/doi.org\/10.1016\/j.ejso.2023.107041.","DOI":"10.1016\/j.ejso.2023.107041"},{"key":"3663_CR24","doi-asserted-by":"publisher","unstructured":"Zhuge L, et al. The optimal number of examined lymph nodes for accurate nodal staging and favorable prognosis of oral tongue squamous cell carcinoma. Oral Oncol. 2023;140:106368. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106368.","DOI":"10.1016\/j.oraloncology.2023.106368"},{"issue":"1","key":"3663_CR25","first-page":"340","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinoma. Am J Cancer Res. 2023;13(1):340\u201351.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"3663_CR26","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-020-09217-8","volume":"28","author":"YZ Zheng","year":"2021","unstructured":"Zheng YZ, et al. Impact of examined lymph node count for esophageal squamous cell carcinoma in patients who underwent right transthoracic esophagectomy. Ann Surg Oncol. 2021;28(6):3025\u201333. https:\/\/doi.org\/10.1245\/s10434-020-09217-8.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3663_CR27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1200\/jco.2016.67.5140","volume":"35","author":"W Liang","year":"2017","unstructured":"Liang W, et al. Impact of examined lymph node count on precise staging and Long-Term survival of resected Non-Small-Cell lung cancer: A population study of the US SEER database and a Chinese Multi-Institutional registry. J Clin Oncol. 2017;35(11):1162\u201370. https:\/\/doi.org\/10.1200\/jco.2016.67.5140.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3663_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10549-019-05500-9","volume":"179","author":"LH Rosenberger","year":"2020","unstructured":"Rosenberger LH, et al. Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? Breast Cancer Res Treat. 2020;179(3):661\u201370. https:\/\/doi.org\/10.1007\/s10549-019-05500-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"3663_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10434-001-0675-3","volume":"8","author":"K Dowlatshahi","year":"2001","unstructured":"Dowlatshahi K, et al. Occult metastases in Sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol. 2001;8(8):675\u201381. https:\/\/doi.org\/10.1007\/s10434-001-0675-3.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3663_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.0.CO;2-7","volume":"88","author":"DL Weaver","year":"2000","unstructured":"Weaver DL, et al. Pathologic analysis of Sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer. 2000;88(5):1099\u2013107.","journal-title":"Cancer"},{"issue":"9","key":"3663_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/0046-8177(93)90108-s","volume":"24","author":"IA Nasser","year":"1993","unstructured":"Nasser IA, et al. Occult axillary lymph node metastases in node-negative breast carcinoma. Hum Pathol. 1993;24(9):950\u20137. https:\/\/doi.org\/10.1016\/0046-8177(93)90108-s.","journal-title":"Hum Pathol"},{"issue":"1","key":"3663_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12885-023-11498-7","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study. BMC Cancer. 2023;23(1):1028. https:\/\/doi.org\/10.1186\/s12885-023-11498-7.","journal-title":"BMC Cancer"},{"issue":"9","key":"3663_CR33","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1097\/js9.0000000000001778","volume":"110","author":"L Qu","year":"2024","unstructured":"Qu L, et al. An unsupervised learning model based on CT radiomics features accurately predicts axillary lymph node metastasis in breast cancer patients: diagnostic study. Int J Surg. 2024;110(9):5363\u201373. https:\/\/doi.org\/10.1097\/js9.0000000000001778.","journal-title":"Int J Surg"},{"issue":"6","key":"3663_CR34","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/1078-0432.Ccr-18-1414","volume":"25","author":"S Shiino","year":"2019","unstructured":"Shiino S, et al. Serum miRNA-based prediction of axillary lymph node metastasis in breast cancer. Clin Cancer Res. 2019;25(6):1817\u201327. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1414.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3663_CR35","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1002\/mp.15873","volume":"49","author":"Y Tang","year":"2022","unstructured":"Tang Y, et al. Radiomics model based on features of axillary lymphatic nodes to predict axillary lymphatic node metastasis in breast cancer. Med Phys. 2022;49(12):7555\u201366. https:\/\/doi.org\/10.1002\/mp.15873.","journal-title":"Med Phys"},{"issue":"5","key":"3663_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.clbc.2023.04.002","volume":"23","author":"X Li","year":"2023","unstructured":"Li X, Yang L, Jiao X. Development and validation of a nomogram for predicting axillary lymph node metastasis in breast cancer. Clin Breast Cancer. 2023;23(5):538\u201345. https:\/\/doi.org\/10.1016\/j.clbc.2023.04.002.","journal-title":"Clin Breast Cancer"},{"key":"3663_CR37","doi-asserted-by":"publisher","unstructured":"Huang YQ, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157\u201364. https:\/\/doi.org\/10.1200\/jco.2015.65.9128.","DOI":"10.1200\/jco.2015.65.9128"},{"issue":"1","key":"3663_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1148\/radiol.220329","volume":"306","author":"Y Bian","year":"2023","unstructured":"Bian Y, et al. Artificial intelligence to predict lymph node metastasis at CT in pancreatic ductal adenocarcinoma. Radiology. 2023;306(1):160\u20139. https:\/\/doi.org\/10.1148\/radiol.220329.","journal-title":"Radiology"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03663-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T18:01:47Z","timestamp":1742666507000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03663-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3663"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03663-w","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required. SEER Program is a publicly available database ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}